Paediatric tuberculosis preventive treatment preferences among HIV-positive children, caregivers and healthcare providers in Eswatini: a discrete choice experiment.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
22 10 2021
Historique:
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 3 11 2021
Statut: epublish

Résumé

Isoniazid preventive therapy initiation and completion rates are suboptimal among children. Shorter tuberculosis (TB) preventive treatment (TPT) regimens have demonstrated safety and efficacy in children and may improve adherence but are not widely used in high TB burden countries. Understanding preferences regarding TPT regimens' characteristics and service delivery models is key to designing services to improve TPT initiation and completion rates. We examined paediatric TPT preferences in Eswatini, a high TB burden country. We conducted a sequential mixed-methods study utilising qualitative methods to inform the design of a discrete choice experiment (DCE) among HIV-positive children, caregivers and healthcare providers (HCP). Drug regimen and service delivery characteristics included pill size and formulation, dosing frequency, medication taste, treatment duration and visit frequency, visit cost, clinic wait time, and clinic operating hours. An unlabelled, binary choice design was used; data were analysed using fixed and mixed effects logistic regression models, with stratified models for children, caregivers and HCP. The study was conducted in 20 healthcare facilities providing TB/HIV care in Manzini, Eswatini, from November 2018 to December 2019. Ninety-one stakeholders completed in-depth interviews to inform the DCE design; 150 children 10-14 years, 150 caregivers and 150 HCP completed the DCE. Despite some heterogeneity, the results were fairly consistent among participants, with palatability of medications viewed as the most important TPT attribute; fewer and smaller pills were also preferred. Additionally, shorter waiting times and cost of visit were found to be significant drivers of choices. Palatable medication, smaller/fewer pills, low visit costs and shorter clinic wait times are important factors when designing TPT services for children and should be considered as new paediatric TPT regimens in Eswatini are rolled out. More research is needed to determine the extent to which preferences drive TPT initiation, adherence and completion rates.

Identifiants

pubmed: 34686549
pii: bmjopen-2020-048443
doi: 10.1136/bmjopen-2020-048443
pmc: PMC8543650
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e048443

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

PLoS One. 2017 Aug 1;12(8):e0182185
pubmed: 28763500
Thorax. 2013 Mar;68(3):247-55
pubmed: 22717944
Soc Sci Med. 1997 Mar;44(5):681-92
pubmed: 9032835
Soc Sci Med. 1999 Sep;49(5):651-61
pubmed: 10452420
Pharmacoeconomics. 2008;26(8):661-77
pubmed: 18620460
Med Decis Making. 1997 Jul-Sep;17(3):307-14
pubmed: 9219191
Health Econ. 2018 Oct;27(10):1550-1566
pubmed: 29926508
J Clin Psychol. 2009 Apr;65(4):368-81
pubmed: 19226606
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
Paediatr Respir Rev. 2011 Mar;12(1):1-2
pubmed: 21172667
BMC Public Health. 2021 Jan 11;21(1):121
pubmed: 33430823
Value Health. 2019 Sep;22(9):1050-1062
pubmed: 31511182
Value Health. 2010 Mar-Apr;13(2):315-23
pubmed: 19912597
Pharmacoeconomics. 2017 Jul;35(7):697-716
pubmed: 28374325
Clin Infect Dis. 2017 Oct 1;65(7):1085-1093
pubmed: 28575208
Value Health. 2011 Sep-Oct;14(6):937-43
pubmed: 21914516
Int J Tuberc Lung Dis. 2004 Apr;8(4):392-402
pubmed: 15141729
Health Econ. 2012 Feb;21(2):145-72
pubmed: 22223558
BMJ. 2000 Jun 3;320(7248):1530-3
pubmed: 10834905
Appl Health Econ Health Policy. 2003;2(1):55-64
pubmed: 14619274
BMC Infect Dis. 2014 Feb 20;14:91
pubmed: 24555539
Int J Tuberc Lung Dis. 2020 Apr 1;24(4):396-402
pubmed: 32317063
NPJ Prim Care Respir Med. 2020 May 11;30(1):21
pubmed: 32393736
PLoS One. 2014 Nov 03;9(11):e111805
pubmed: 25365169
Int J Tuberc Lung Dis. 2018 Aug 1;22(8):858-862
pubmed: 29991393

Auteurs

Yael Hirsch-Moverman (Y)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, New York, USA yh154@columbia.edu.
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.

Michael Strauss (M)

Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.

Gavin George (G)

Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.

Anthony Mutiti (A)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, New York, USA.

Arnold Mafukidze (A)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, New York, USA.

Siphesihle Shongwe (S)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, New York, USA.

Gloria Sisi Dube (GS)

Eswatini National TB Control Programme, Eswatini Ministry of Health, Mbabane, Hhohho, Swaziland.

Wafaa M El Sadr (WM)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, New York, USA.
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.

Joanne E Mantell (JE)

Department of Psychiatry, Gender, Sexuality and Health Area, New York State Psychiatric Institute and Department of Psychiatry, Columbia University Irving Medical Center, New York, New York, USA.

Andrea A Howard (AA)

ICAP at Columbia University, Columbia University Mailman School of Public Health, New York, New York, USA.
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH